









Markets
/
Stocks
/
nasdaq-elab
/

PMGC Holdings Inc

ELAB

1.760USD

+0.160+10.00%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

327.41KMarket Cap

0.00P/E TTM



PMGC Holdings Inc

1.760

+0.160+10.00%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of PMGC Holdings Inc

Currency: USD Updated: 2026-02-06

Key Insights

PMGC Holdings Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 68 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

PMGC Holdings Inc's Score

Industry at a Glance

Industry Ranking

68 / 75

Overall Ranking

522 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

PMGC Holdings Inc Highlights

StrengthsRisks

PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. The Company's portfolio consists of various subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., PMGC Capital LLC, and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. AGA Precision Systems LLC specializes in CNC machining operations.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 0.00.

Fairly Valued

The company’s latest PE is 0.00, at a medium 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 445.00 shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of PMGC Holdings Inc is 5.67, ranking 68 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 285.95K, representing a year-over-year decrease of 45.79%, while its net profit experienced a year-over-year decrease of 72.81%.

Score

Industry at a Glance

Previous score

5.67

Change



Financials

9.19

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.01

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.83

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

2.18

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.11

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

PMGC Holdings Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of PMGC Holdings Inc is 8.17, ranking 15 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 0.00, which is 12000.00% below the recent high of 0.05 and 5567075.00% above the recent low of -22.27.

Score

Industry at a Glance

Previous score

8.17

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 68/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for PMGC Holdings Inc. The Healthcare Providers & Services industry's average is 7.58.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of PMGC Holdings Inc is 2.06, ranking 74 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 4.43 and the support level at 0.30, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.19

Change

-0.13

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.424

Neutral

RSI(14)

19.072

Oversold

STOCH(KDJ)(9,3,3)

9.859

Oversold

ATR(14)

0.402

Low Volatility

CCI(14)

-135.621

Sell

Williams %R

89.655

Oversold

TRIX(12,20)

-4.302

Sell

StochRSI(14)

38.260

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.146

Sell

MA10

2.781

Sell

MA20

3.328

Sell

MA50

8.929

Sell

MA100

14.228

Sell

MA200

10.827

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Streeterville Capital LLC

16.75K

L1 Global Manager Pty Limited

11.83K

+20291.38%

Geode Capital Management, L.L.C.

520.00

The Vanguard Group, Inc.

Star Investors

445.00

UBS Financial Services, Inc.

29.00

-85.57%

BWL Investments Ltd

140.00

Tower Research Capital LLC

116.00

+114.81%

MOA Life Plus Co,Ltd.

48.00

Citi Investment Research (US)

46.00

GB Capital Ltd

43.00

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of PMGC Holdings Inc is 1.04, ranking 71 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.